J. Lanciego

发表

Functional neuroanatomy of the basal ganglia.

J. Obeso, J. Lanciego, N. Luquin, 2012, Cold Spring Harbor perspectives in medicine.

Current concepts in neuroanatomical tracing

J. Lanciego, S. Thanos, C. Köbbert, 2000, Progress in Neurobiology.

Multiple neuroanatomical tracing in primates.

J. Lanciego, J. Giménez-Amaya, M. Luquin, 1998, Brain research. Brain research protocols.

Pathophysiology of the basal ganglia in Parkinson's disease

J. Obeso, J. Lanciego, M. Rodriguez-Oroz, 2000, Trends in Neurosciences.

Thalamic interaction between the input and the output systems of the basal ganglia

Elena Erro, J. Lanciego, S. D. L. Heras, 1999, Journal of Chemical Neuroanatomy.

Parkinson's Disease: Cell Vulnerability and Disease Progression

J. Obeso, J. Lanciego, J. Blesa, 2015 .

Considerations on the thalamostriatal system with some functional implications.

J. Lanciego, E. Mengual, J. Giménez-Amaya, 2000, Histology and histopathology.

Past, Present, and Future of the Pathophysiological Model of the Basal Ganglia

José A. Obeso, José L. Lanciego, J. Obeso, 2011, Front. Neuroanat..

Gene therapy approaches in the non-human primate model of Parkinson’s disease

J. Lanciego, Kazuto Kobayashi, S. Kato, 2018, Journal of Neural Transmission.

Interactions between Calmodulin, Adenosine A2A, and Dopamine D2 Receptors*

K. Fuxe, D. Marcellino, L. Agnati, 2009, The Journal of Biological Chemistry.

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes

J. Lanciego, R. Franco, Gemma Navarro, 2018, Front. Neuroanat..

A re-examination of the striatal input from the mediodorsal thalamic nucleus in the rat

J. Lanciego, J. Giménez-Amaya, M. Erro, 2000 .

The added value of rabies virus as a retrograde tracer when combined with dual anterograde tract-tracing

J. Lanciego, P. Salin, L. Goff, 2010, Journal of Neuroscience Methods.

The parafascicular thalamic complex and basal ganglia circuitry: further complexity to the basal ganglia model

J. Obeso, J. Lanciego, N. Gonzalo, 2002 .

A sequential protocol combining dual neuroanatomical tract-tracing with the visualization of local circuit neurons within the striatum

J. Lanciego, N. Gonzalo, M. Castle, 2001, Journal of Neuroscience Methods.

The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP

J. Lanciego, M. Luquin, P. Garrido-Gil, 2007, Synapse.

Elsevier Editorial System(tm) for Journal of Chemical Neuroanatomy Manuscript Draft Title: a Half Century of Experimental Neuroanatomical Tracing a Half Century of Experimental Neuroanatomical Tracing *manuscript Click Here to View Linked References

J. Lanciego, F. Wouterlood, Luis Jose, 2022 .

Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

J. Lanciego, T. González-Hernández, J. Castro-Hernandez, 2014, Front. Neuroanat..

Differential organization of cortical inputs to striatal projection neurons of the matrix compartment in rats

J. Lanciego, A. Reiner, P. Salin, 2015, Front. Syst. Neurosci..

Retrograde Tract-Tracing “Plus”: Adding Extra Value to Retrogradely Traced Neurons

J. Lanciego, 2015 .

Distribution of Relaxin‐3 mRNA and Immunoreactivity and RXFP3‐Binding Sites in the Brain of the Macaque, Macaca fascicularis

J. Lanciego, A. Gundlach, Sherie Ma, 2009, Annals of the New York Academy of Sciences.

Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates

J. Lanciego, R. Franco, Gemma Navarro, 2020, Brain Structure and Function.

Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB)

J. Lanciego, N. Luquin, R. Franco, 2012, Neurobiology of Disease.

Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2012, AGE.

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine

J. Lanciego, R. Cilia, A. Schapira, 2019, Movement disorders : official journal of the Movement Disorder Society.

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

J. Lanciego, M. Alegre, F. Corrales, 2022, Science Translational Medicine.

Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings

J. Lanciego, M. Luquin, P. Pástor, 2019, Journal of Neurology.

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives

J. Lanciego, A. J. Rico, E. Roda, 2022, Biomedicines.

Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum

J. Lanciego, R. Franco, V. Casadó, 2016, Molecular Neurobiology.

Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

J. Lanciego, R. Franco, D. Henrion, 2016, Cell Death and Disease.

Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2015, Neurobiology of Aging.

The basal ganglia and thalamus of the long-tailed macaque in stereotaxic coordinates. A template atlas based on coronal, sagittal and horizontal brain sections

J. Lanciego, Alfonso Vázquez, 2011, Brain Structure and Function.

Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain*

J. Lanciego, J. Mallol, C. Lluis, 2012, The Journal of Biological Chemistry.

Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

J. Lanciego, N. Luquin, R. Franco, 2014, Brain Structure and Function.

Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System

J. Lanciego, G. González-Aseguinolaza, Á. Vales, 2017, Front. Neuroanat..

Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease

J. Lanciego, M. Casarejos, Tresa López-Royo, 2018, Glia.

Two types of periglomerular cells in the olfactory bulb of the macaque monkey (Macaca fascicularis)

J. Lanciego, J. Nacher, Emilio Varea, 2013, Brain Structure and Function.

Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

J. Lanciego, J. Manzanares, R. Franco, 2018, Neurotherapeutics.

Visualizing advances in the future of primate neuroscience research

Anna S. Mitchell, N. Logothetis, M. Poo, 2022, Current research in neurobiology.

Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels

J. Lanciego, R. Franco, J. Oyarzábal, 2016, Journal of neurochemistry.

A half century of experimental neuroanatomical tracing

Floris G. Wouterlood, José L. Lanciego, J. Lanciego, 2011, Journal of Chemical Neuroanatomy.

Projections from the primary auditory cortex onto the dorsal cortex of the inferior colliculus in albino rats.

J. Lanciego, M. Herrera, J. Hurtado-García, 1994, Archives italiennes de biologie.

Increased vulnerability to ethanol consumption in adolescent maternal separated mice

J. Lanciego, J. Manzanares, G. Rubio, 2016, Addiction biology.

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2017, Front. Aging Neurosci..

Detection of two different mRNAs in a single section by dual in situ hybridization: A comparison between colorimetric and fluorescent detection

J. Lanciego, E. Erro, T. Tuñón, 2007, Journal of Neuroscience Methods.

Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay

J. Lanciego, R. Franco, O. Rabal, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Julen Oyarzabal, Pier Andrea Borea, Gemma Navarro, 2017, Front. Pharmacol..

Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.

J. Lanciego, C. Müller, R. Franco, 2014, Journal of neuropathology and experimental neurology.

AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy.

L. Leocani, J. Lanciego, S. Taverna, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

The origin of motor fluctuations in Parkinson’s disease

J. Obeso, J. Lanciego, M. Rodriguez-Oroz, 2004, Neurology.

Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

J. Lanciego, C. Lluis, R. Franco, 2011, Journal of psychopharmacology.

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

J. Lanciego, J. Kulisevsky, D. Sucunza, 2018, Neurotherapeutics.

Neuroanatomical tracing combined with in situ hybridization: Analysis of gene expression patterns within brain circuits of interest

J. Lanciego, F. Wouterlood, P. Barroso-Chinea, 2010, Journal of Neuroscience Methods.

‘Functional’ neuroanatomical tract tracing: Analysis of changes in gene expression of brain circuits of interest

José L. Lanciego, J. Lanciego, P. Barroso-Chinea, 2006, Brain Research.

Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines

J. Lanciego, B. Meléndez, J. Rey, 2021, Biology.

Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans

J. Lanciego, J. Parga, J. Labandeira-Garcia, 2017, Molecular Neurobiology.

Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum.

J. Lanciego, R. Franco, Gemma Navarro, 2015, Biochemical pharmacology.

Glutamatergic pallidothalamic projections and their implications in the pathophysiology of Parkinson’s disease

J. Lanciego, D. Luis-Ravelo, P. Barroso-Chinea, 2008, Neurobiology of Disease.

Classic and Contemporary Neural Tract-Tracing Techniques

Deepak N. Pandya, Robert J. Morecraft, Floris G. Wouterlood, 2009 .

Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primates.

J. Lanciego, J. Prieto, H. Petry, 2011, Human gene therapy.

Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys.

Elisa Garbayo, J. Lanciego, M. Luquin, 2016, Biomaterials.

Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

J. Lanciego, C. Montero-Menei, E. Ansorena, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques

J. Lanciego, D. Pignataro, D. Sucunza, 2014, Front. Neuroanat..

Production of highly pure human glycosylated GDNF in a mammalian cell line.

J. Lanciego, E. Ansorena, E. Garbayo, 2010, International journal of pharmaceutics.

Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment

J. Lanciego, M. Ávila, C. Cabanne, 2022, Life.

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

J. Lanciego, J. Kulisevsky, D. Sucunza, 2018, Neurotherapeutics.

Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2017, Brain Structure and Function.

Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra

J. Lanciego, J. Labandeira-Garcia, R. Valenzuela, 2012, Brain Structure and Function.

G‐Protein‐Coupled Receptor Heteromers as Key Players in the Molecular Architecture of the Central Nervous System

J. Lanciego, R. Franco, V. Casadó, 2014, CNS neuroscience & therapeutics.

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson’s Research, Both for Disease Modeling Purposes and for Therapeutic Uses

J. Lanciego, A. J. Rico, E. Roda, 2021, International journal of molecular sciences.

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization

J. Lanciego, R. Franco, Gemma Navarro, 2016, Front. Pharmacol..

AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2022, Brain, Behavior, and Immunity.

Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

J. Lanciego, J. Ávila, F. Hernández, 2021, Acta neuropathologica communications.

Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease

J. Lanciego, R. Franco, J. Oyarzábal, 2019, Molecular neurobiology.

Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra

J. Lanciego, J. Labandeira-Garcia, R. Valenzuela, 2012, Brain Structure and Function.

Location of Prorenin Receptors in Primate Substantia Nigra: Effects on Dopaminergic Cell Death

J. Lanciego, P. Barroso-Chinea, J. Labandeira-Garcia, 2010, Journal of neuropathology and experimental neurology.

Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2013, AGE.

Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2010, Experimental Neurology.

Usefulness of identifying G-protein-coupled receptor dimers for diagnosis and therapy of neurodegenerative diseases and of gliomas.

J. Lanciego, R. Franco, Gemma Navarro, 2018, Histology and histopathology.

Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

J. Lanciego, J. Mallol, C. Lluis, 2015, Molecular Neurobiology.

CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum

J. Lanciego, R. Franco, Gemma Navarro, 2014, Experimental Neurology.

l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus

J. Lanciego, N. Luquin, C. Müller, 2014, Neuropharmacology.

Cannabinoid receptors CB 1 and CB 2 form functional heteromers in the brain #

J. Lanciego, J. Mallol, C. Lluis, 2012 .

Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD

J. Lanciego, R. Franco, J. Oyarzábal, 2013, Neuropharmacology.

Glucocerebrosidase expression patterns in the non-human primate brain

J. Lanciego, D. Pignataro, D. Sucunza, 2017, Brain Structure and Function.

Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

J. Lanciego, J. Manzanares, R. Franco, 2018, Neurotherapeutics.

Multiple Neuroanatomical Tract-Tracing: Approaches for Multiple Tract-Tracing

Floris G. Wouterlood, José L. Lanciego, J. Lanciego, 2006 .

Expression of vesicular glutamate transporters 1 and 2 in the cells of origin of the rat thalamostriatal pathway

J. Lanciego, P. Barroso-Chinea, M. Aymerich, 2008, Journal of Chemical Neuroanatomy.

Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum

J. Lanciego, R. Franco, Gemma Navarro, 2020, Annals of the New York Academy of Sciences.

Expression of the mRNAs encoding for the vesicular glutamate transporters 1 and 2 in the rat thalamus

J. Lanciego, E. Erro, T. Tuñón, 2007, The Journal of comparative neurology.

Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease

J. Lanciego, J. Oyarzábal, Gemma Navarro, 2019, Molecular Neurobiology.

Phosphodiesterase inhibition in cognitive decline.

J. Lanciego, R. Franco, J. Oyarzábal, 2014, Journal of Alzheimer's disease : JAD.

Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

J. Lanciego, Manuel Rodriguez, T. González-Hernández, 2009, Neurobiology of Disease.

Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum

J. Lanciego, R. Franco, V. Casadó, 2016, Molecular Neurobiology.

Ischemia induces cell proliferation and neurogenesis in the gerbil hippocampus in response to neuronal death

J. Lanciego, J. Rı́o, D. Frechilla, 2008, Neuroscience Research.

Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease

J. Lanciego, E. Ansorena, E. Garbayo, 2011, Movement disorders : official journal of the Movement Disorder Society.

Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor.

J. Lanciego, E. Ansorena, E. Garbayo, 2007, International journal of pharmaceutics.

A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys

J. Obeso, J. Lanciego, P. Barroso-Chinea, 2010, Neurobiology of Disease.

Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi‐ and contralateral projections

J. Obeso, J. Lanciego, N. Gonzalo, 2005, The Journal of comparative neurology.

Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus

Jose A Obeso, J. Obeso, J. Lanciego, 2004, The European journal of neuroscience.

Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease

J. Lanciego, A. Rodriguez-Perez, J. Labandeira-Garcia, 2013, Neurobiology of Disease.

Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation

J. Lanciego, R. Franco, S. George, 2016, Brain Structure and Function.

J. Lanciego, R. Franco, Gemma Navarro, 2021, Redox biology.

Neuroanatomical tract-tracing techniques that did go viral

Jose L. Lanciego, Floris G. Wouterlood, J. Lanciego, 2020, Brain Structure and Function.

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

J. Lanciego, C. Müller, R. Franco, 2011, Pharmacology & therapeutics.

Past , present and future of A 2 A adenosine receptor antagonists in the therapy of Parkinson ’ s disease

J. Lanciego, R. Franco, S. Ferré, 2011 .

Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease

J. Lanciego, J. Manzanares, A. Aracil-Fernández, 2018, Neurotherapeutics.

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

K. Fuxe, D. Borroto-Escuela, J. Lanciego, 2018, Brain, Behavior, and Immunity.

Loss of Parvalbumin-Positive Neurons From the Globus Pallidus in Animal Models of Parkinson Disease

J. Lanciego, R. Franco, M. Aymerich, 2012, Journal of neuropathology and experimental neurology.

Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.

J. Lanciego, E. Ansorena, E. Garbayo, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans

J. Lanciego, J. Parga, J. Labandeira-Garcia, 2017, Molecular Neurobiology.

How does Parkinson's disease begin? The role of compensatory mechanisms

J. Obeso, J. Lanciego, M. Rodriguez-Oroz, 2004, Trends in Neurosciences.

Neuroanatomical Tract-Tracing 3

Floris G. Wouterlood, Laszlo Zaborszky, José L. Lanciego, 2006 .

History and future challenges of the subthalamic nucleus as surgical target: Review article

J. Lanciego, J. Guridi, R. Rodríguez-Rojas, 2018, Movement disorders : official journal of the Movement Disorder Society.

The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson’s disease

J. Lanciego, N. Gonzalo, E. Erro, 2009, Brain Research Bulletin.

Lesion of the centromedian thalamic nucleus in MPTP‐treated monkeys

Y. Smith, J. Obeso, J. Lanciego, 2008, Movement disorders : official journal of the Movement Disorder Society.

Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats

J. Lanciego, T. González-Hernández, M. Moreno-Igoa, 2006, The European journal of neuroscience.

Re-examination of the thalamostriatal projections in the rat with retrograde tracers

J. Lanciego, J. Giménez-Amaya, M. Erro, 2002, Neurosciences research.

Relationships between thalamostriatal neurons and pedunculopontine projections to the thalamus: a neuroanatomical tract-tracing study in the rat

J. Lanciego, J. Giménez-Amaya, E. Erro, 1999, Experimental Brain Research.

Intralaminar Thalamic Nuclei are Main Regulators of Basal Ganglia

J. Obeso, J. Lanciego, P. Salin, 2005 .

Origin of calretinin‐containing, vesicular glutamate transporter 2‐coexpressing fiber terminals in the entorhinal cortex of the rat

M. Witter, J. Lanciego, F. Wouterlood, 2008, The Journal of comparative neurology.

Complex brain circuits studied via simultaneous and permanent detection of three transported neuroanatomical tracers in the same histological section

J. L Lanciego, F. G Wouterlood, E Erro, 2000, Journal of Neuroscience Methods.

Multiple axonal tracing: simultaneous detection of three tracers in the same section

Floris G. Wouterlood, José L. Lanciego, Elena Erro, 1998, Histochemistry and Cell Biology.

Use of peroxidase substrate Vector VIP® for multiple staining in light microscopy

Floris G Wouterlood, Menno P Witter, M. Witter, 1997, Journal of Neuroscience Methods.

Disruption of a dopamine receptor complex amplifies the actions of cocaine

P. Fletcher, J. Lanciego, R. Franco, 2016, European Neuropsychopharmacology.

Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells

J. Lanciego, T. González-Hernández, D. Afonso-Oramas, 2005, The European journal of neuroscience.

[Neuroprotective and neurorestorative therapies for the treatment of Parkinson's disease].

J. Lanciego, E. Ansorena, E. Garbayo, 2006, Anales del sistema sanitario de Navarra.

Basal Ganglia Circuits: What's Now and Next?

J. Lanciego, 2012, Front. Neuroanat..

Notes on the combined use of V-VIP and DAB peroxidase substrates for the detection of colocalising antigens

J. Lanciego, J. Giménez-Amaya, J. L. Lanciego, 1999, Histochemistry and Cell Biology.

Chapter 17 – Classic and Contemporary Neural Tract-Tracing Techniques

D. Pandya, J. Lanciego, F. Wouterlood, 2014 .

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques

J. Lanciego, V. Broccoli, G. González-Aseguinolaza, 2021, International journal of molecular sciences.

A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.

J. Lanciego, J. Kulisevsky, J. Marín-Lahoz, 2023, Parkinsonism & related disorders.

Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy

J. Lanciego, M. Zelaya, M. E. Erro Aguirre, 2015, Front. Neuroanat..

Synaptic connectivity of the cholinergic axons in the olfactory bulb of the cynomolgus monkey

J. Lanciego, J. Nacher, Emilio Varea, 2015, Front. Neuroanat..

Glutamatergic and cholinergic pedunculopontine neurons innervate the thalamic parafascicular nucleus in rats: changes following experimental parkinsonism

J. Lanciego, N. Luquin, P. Barroso-Chinea, 2011, Brain Structure and Function.

Localization of relaxin‐3 in brain of Macaca fascicularis: Identification of a nucleus incertus in primate

J. Lanciego, A. Gundlach, Sherie Ma, 2009, The Journal of comparative neurology.

Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism

Francois Gonon, Nicolas Mallet, E. Bézard, 2008, The European journal of neuroscience.

Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson's disease

J. Lanciego, P. Salin, L. Goff, 2009, Neurobiology of Disease.

Neuroanatomical tract-tracing methods beyond 2000: what's now and next

J. L Lanciego, F. G Wouterlood, J. Lanciego, 2000, Journal of Neuroscience Methods.

["Neurorestorative" cell therapy in Parkinson's disease: an unresolved debate].

J. Obeso, J. Lanciego, M. Rodriguez-Oroz, 2004, Anales del sistema sanitario de Navarra.

Pallidothalamic-projecting neurons in Macaca fascicularis co-express GABAergic and glutamatergic markers as seen in control, MPTP-treated and dyskinetic monkeys

J. Lanciego, N. Luquin, P. Barroso-Chinea, 2011, Brain Structure and Function.

High-resolution neuroanatomical tract-tracing for the analysis of striatal microcircuits

J. Lanciego, P. Salin, L. Goff, 2008, Brain Research.

Neuroanatomical tract-tracing 3 : molecules, neurons, and systems

Lennart Heimer, Floris G. Wouterlood, Laszlo Zaborszky, 2006 .

Basal Ganglia Circuits

J. Lanciego, 2012 .

Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

J. Lanciego, M. Vila, I. Peñuelas, 2023, bioRxiv.

Striatal input from the ventrobasal complex of the rat thalamus

J. Lanciego, J. Giménez-Amaya, M. Erro, 2001, Histochemistry and Cell Biology.